Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of Cyclin D3 down regulation

Peng Wang, Z. Steven Pavletic, Shantaram S Joshi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

B-cell chronic lymphocytic leukemia (CLL) is a clonal B cell malignancy of morphologically mature, functionally immature B cells. B-cell CLL cells are known to be resistant to killing by anticancer and other agents. This resistance is associated with alterations in apoptosis and cell cycle regulated genes. In our earlier studies, we have demonstrated that CLL cells have differential expression of genes that are associated with apoptosis and cell cycle regulation, including elevated expression of Bcl-2, DAD-1, Cyclin D3 and cyclin dependent kinase 4 inhibitor. Therefore, in this study, in an attempt to study the role of Cyclin D3 in the resistant behavior of CLL cells, Cyclin D3 was down regulated using antisense oligonucleotide (AS-ODN) in WSU-CLL, a human CLL cell line. The down regulation of Cyclin D3 was confirmed by RT-PCR and flow cytometry techniques. The Cyclin D3 expression down-regulated WSU-CLL cells were then tested for their susceptibility to fludarabine, a chemotherapeutic agent. Our results showed that the Cyclin D3 expression down-regulated WSU-CLL cells were more susceptible to fludarabine mediated killing. Following treatment with fludarabine, there was a significant increase in the number of cells undergoing apoptosis in Cyclin D3 expression down-regulated WSU-CLL cells as determined by Annexin-V assay, cell cycle analysis for DNA content, and cytomorphology. Thus, our results indicate Cyclin D3 down regulation increases the killing of WSU-CLL cells with fludarabine by increasing the number of cells undergoing apoptosis.

Original languageEnglish (US)
Pages (from-to)1827-1835
Number of pages9
JournalLeukemia and Lymphoma
Volume43
Issue number9
DOIs
StatePublished - Aug 24 2002

Fingerprint

Cyclin D3
B-Cell Chronic Lymphocytic Leukemia
Down-Regulation
Apoptosis
Cell Cycle
Cell Count
Cyclin-Dependent Kinase 4
cdc Genes
B-Lymphoid Precursor Cells
Antisense Oligonucleotides
Annexin A5
Antineoplastic Agents
Flow Cytometry
B-Lymphocytes

Keywords

  • Antisense oligonucleotide
  • Apoptosis
  • B-chronic lymphocytic leukemia
  • Cyclin D3
  • Fludarabine

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of Cyclin D3 down regulation. / Wang, Peng; Pavletic, Z. Steven; Joshi, Shantaram S.

In: Leukemia and Lymphoma, Vol. 43, No. 9, 24.08.2002, p. 1827-1835.

Research output: Contribution to journalArticle

@article{e6fb4459c4c8498696add5f680b12472,
title = "Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of Cyclin D3 down regulation",
abstract = "B-cell chronic lymphocytic leukemia (CLL) is a clonal B cell malignancy of morphologically mature, functionally immature B cells. B-cell CLL cells are known to be resistant to killing by anticancer and other agents. This resistance is associated with alterations in apoptosis and cell cycle regulated genes. In our earlier studies, we have demonstrated that CLL cells have differential expression of genes that are associated with apoptosis and cell cycle regulation, including elevated expression of Bcl-2, DAD-1, Cyclin D3 and cyclin dependent kinase 4 inhibitor. Therefore, in this study, in an attempt to study the role of Cyclin D3 in the resistant behavior of CLL cells, Cyclin D3 was down regulated using antisense oligonucleotide (AS-ODN) in WSU-CLL, a human CLL cell line. The down regulation of Cyclin D3 was confirmed by RT-PCR and flow cytometry techniques. The Cyclin D3 expression down-regulated WSU-CLL cells were then tested for their susceptibility to fludarabine, a chemotherapeutic agent. Our results showed that the Cyclin D3 expression down-regulated WSU-CLL cells were more susceptible to fludarabine mediated killing. Following treatment with fludarabine, there was a significant increase in the number of cells undergoing apoptosis in Cyclin D3 expression down-regulated WSU-CLL cells as determined by Annexin-V assay, cell cycle analysis for DNA content, and cytomorphology. Thus, our results indicate Cyclin D3 down regulation increases the killing of WSU-CLL cells with fludarabine by increasing the number of cells undergoing apoptosis.",
keywords = "Antisense oligonucleotide, Apoptosis, B-chronic lymphocytic leukemia, Cyclin D3, Fludarabine",
author = "Peng Wang and Pavletic, {Z. Steven} and Joshi, {Shantaram S}",
year = "2002",
month = "8",
day = "24",
doi = "10.1080/1042819021000006411",
language = "English (US)",
volume = "43",
pages = "1827--1835",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of Cyclin D3 down regulation

AU - Wang, Peng

AU - Pavletic, Z. Steven

AU - Joshi, Shantaram S

PY - 2002/8/24

Y1 - 2002/8/24

N2 - B-cell chronic lymphocytic leukemia (CLL) is a clonal B cell malignancy of morphologically mature, functionally immature B cells. B-cell CLL cells are known to be resistant to killing by anticancer and other agents. This resistance is associated with alterations in apoptosis and cell cycle regulated genes. In our earlier studies, we have demonstrated that CLL cells have differential expression of genes that are associated with apoptosis and cell cycle regulation, including elevated expression of Bcl-2, DAD-1, Cyclin D3 and cyclin dependent kinase 4 inhibitor. Therefore, in this study, in an attempt to study the role of Cyclin D3 in the resistant behavior of CLL cells, Cyclin D3 was down regulated using antisense oligonucleotide (AS-ODN) in WSU-CLL, a human CLL cell line. The down regulation of Cyclin D3 was confirmed by RT-PCR and flow cytometry techniques. The Cyclin D3 expression down-regulated WSU-CLL cells were then tested for their susceptibility to fludarabine, a chemotherapeutic agent. Our results showed that the Cyclin D3 expression down-regulated WSU-CLL cells were more susceptible to fludarabine mediated killing. Following treatment with fludarabine, there was a significant increase in the number of cells undergoing apoptosis in Cyclin D3 expression down-regulated WSU-CLL cells as determined by Annexin-V assay, cell cycle analysis for DNA content, and cytomorphology. Thus, our results indicate Cyclin D3 down regulation increases the killing of WSU-CLL cells with fludarabine by increasing the number of cells undergoing apoptosis.

AB - B-cell chronic lymphocytic leukemia (CLL) is a clonal B cell malignancy of morphologically mature, functionally immature B cells. B-cell CLL cells are known to be resistant to killing by anticancer and other agents. This resistance is associated with alterations in apoptosis and cell cycle regulated genes. In our earlier studies, we have demonstrated that CLL cells have differential expression of genes that are associated with apoptosis and cell cycle regulation, including elevated expression of Bcl-2, DAD-1, Cyclin D3 and cyclin dependent kinase 4 inhibitor. Therefore, in this study, in an attempt to study the role of Cyclin D3 in the resistant behavior of CLL cells, Cyclin D3 was down regulated using antisense oligonucleotide (AS-ODN) in WSU-CLL, a human CLL cell line. The down regulation of Cyclin D3 was confirmed by RT-PCR and flow cytometry techniques. The Cyclin D3 expression down-regulated WSU-CLL cells were then tested for their susceptibility to fludarabine, a chemotherapeutic agent. Our results showed that the Cyclin D3 expression down-regulated WSU-CLL cells were more susceptible to fludarabine mediated killing. Following treatment with fludarabine, there was a significant increase in the number of cells undergoing apoptosis in Cyclin D3 expression down-regulated WSU-CLL cells as determined by Annexin-V assay, cell cycle analysis for DNA content, and cytomorphology. Thus, our results indicate Cyclin D3 down regulation increases the killing of WSU-CLL cells with fludarabine by increasing the number of cells undergoing apoptosis.

KW - Antisense oligonucleotide

KW - Apoptosis

KW - B-chronic lymphocytic leukemia

KW - Cyclin D3

KW - Fludarabine

UR - http://www.scopus.com/inward/record.url?scp=0036347972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036347972&partnerID=8YFLogxK

U2 - 10.1080/1042819021000006411

DO - 10.1080/1042819021000006411

M3 - Article

C2 - 12685840

AN - SCOPUS:0036347972

VL - 43

SP - 1827

EP - 1835

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 9

ER -